A randomized, double-blind, placebo-controlled, parallel group study to evaluate the efficacy and safety of dupilumab in children 6 to <12 years of age with uncontrolled persistent asthma STUDY NUMBER: EFC14153
Administered By
Awarded By
Contributors
- Lang, Jason Principal Investigator
Start/End
- October 25, 2017 - September 30, 2019